Ascendiant Capital Markets Comments on Aemetis Q3 Earnings

Aemetis, Inc (NASDAQ:AMTX) – Investment analysts at Ascendiant Capital Markets lifted their Q3 2026 earnings per share (EPS) estimates for shares of Aemetis in a note issued to investors on Wednesday, August 19th. Ascendiant Capital Markets analyst E. Woo now expects that the specialty chemicals company will post earnings of ($0.18) per share for the quarter, up from their previous forecast of ($0.22). Ascendiant Capital Markets has a “Buy” rating and a $22.00 price target on the stock. The consensus estimate for Aemetis’ current full-year earnings is ($0.98) per share. Ascendiant Capital Markets also issued estimates for Aemetis’ Q4 2026 earnings at ($0.19) EPS, FY2026 earnings at ($0.85) EPS, Q1 2027 earnings at ($0.16) EPS, Q2 2027 earnings at ($0.14) EPS, Q3 2027 earnings at ($0.12) EPS, Q4 2027 earnings at ($0.10) EPS and FY2027 earnings at ($0.52) EPS.

Aemetis (NASDAQ:AMTX) last issued its quarterly earnings results on Thursday, August 6th. The specialty chemicals company reported ($0.13) earnings per share for the quarter, topping the consensus estimate of ($0.29) by $0.16. The company had revenue of $62.70 million for the quarter, compared to analysts’ expectations of $67.69 million.

Other analysts have also issued reports about the stock. Weiss Ratings restated a “sell (e+)” rating on shares of Aemetis in a research note on Friday, July 17th. Wall Street Zen upgraded shares of Aemetis from a “sell” rating to a “hold” rating in a research note on Saturday. One research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average target price of $11.88.

Aemetis Stock Performance

Shares of AMTX opened at $1.89 on Tuesday. Aemetis has a 1 year low of $1.30 and a 1 year high of $3.80. The stock has a market capitalization of $136.40 million, a PE ratio of -2.08 and a beta of 1.48. The stock has a 50-day simple moving average of $1.70 and a 200-day simple moving average of $2.08.

Institutional Trading of Aemetis

Hedge funds and other institutional investors have recently bought and sold shares of the business. Royal Bank of Canada lifted its holdings in Aemetis by 10,632.5% during the 1st quarter. Royal Bank of Canada now owns 8,908 shares of the specialty chemicals company’s stock worth $28,000 after buying an additional 8,825 shares during the last quarter. Sanctuary Advisors LLC purchased a new position in shares of Aemetis in the 1st quarter valued at about $33,000. Creative Planning purchased a new position in shares of Aemetis in the 2nd quarter valued at about $30,000. Prairiewood Capital LLC acquired a new stake in shares of Aemetis during the 1st quarter worth about $47,000. Finally, Engineers Gate Manager LP acquired a new stake in shares of Aemetis during the 2nd quarter worth about $42,000. 27.02% of the stock is currently owned by institutional investors and hedge funds.

Aemetis Company Profile

Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.

Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.